Targeting astrocyte-mediated neurotoxicity induced by ALS/FTD-associated RNA binding proteins
DHE mitigates astrocyte-driven neurotoxicity associated with ALS/FTD-related RNA-binding protein pathology by suppressing inflammatory signaling and enhancing antioxidant defense mechanisms and highlights astrocyte-mediated signaling pathways as actionable targets in neurodegenerative disease.